Management of right-to-left shunt in cryptogenic cerebrovascular disease: Results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry

Journal of Neurology

Volumn 260, Issue 1, 2013, Pages 260-267

  Horner, Susanna ^a   Niederkorn, Kurt ^a   Gattringer, Thomas ^a   Furtner, Martin ^b   Topakian, Raffi ^c   Lang, Wilfried ^d   Maier, Robert ^a   Gamillscheg, Andreas ^a   Fazekas, Franz ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c KEPLER UNIVERSITY HOSPITAL   (Austria)

^d KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

Cryptogenic stroke; Paradoxical cerebral embolism; Patent foramen ovale; Pulmonary arteriovenous malformation; Right to left shunt; Transcatheter closure

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; AUSTRIA; BRAIN INFARCTION; CATHETER; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; FEMALE; HEART RIGHT LEFT SHUNT; HUMAN; LUNG ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AUSTRIA; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FEMALE; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; OBSERVATION; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; YOUNG ADULT;

EID: 84872315042     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6629-9     Document Type: Article

References (24)

1. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740-1746
2. Overell JR, Bone I, Lees KR (2000) Intraatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55:1172-1179
3. Homma S, Sacco RL (2005) Patent foramen ovale and stroke. Circulation 112:1063-1072
4. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25(5):457-507 (Epub 6 May 2008)
5. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN (2011) American heart association stroke council, council on cardiovascular nursing, council on clinical cardiology, and interdisciplinary council on quality of care and outcomes research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 42(1):227-276
6. Kenny D, Turner M, Martin R (2008) When to close a patent foramen ovale. Arch Dis Child 93(3):255-259
7. Kitsios GD, Dahabreh IJ, Abu Dabrh AM, Thaler DE, Kent DM (2012) Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke 43(2):422-431 (Epub 15 Dec 2011)
8. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A (2012) Closure I investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366(11):991-999
9. Kimura K, Minematsu K, Nakajima M (2004) Isolated pulmonary arteriovenous fistula without Rendu-Osler-Weber disease as a cause of cryptogenic stroke. J Neurol Neurosurg Psychiatry 75(2):311-313
10. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV (2006) American heart association; American stroke association stroke council. Primary prevention of ischemic stroke: a guideline from the American heart association/American stroke association stroke council: cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group. Circulation 113(24):e873-e923
11. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864-870
12. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, Van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(5):604-607
13. Gossage JR (2003) The role of echocardiography in screening for pulmonary arterivenous malformations. Chest 123:320-322
14. Jauss M, Zanette E (2000) Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 10(6):490-496
15. Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, Markus HS, Russel D, Siebler M (1998) Consensus on microembolus detection by TCD. International consensus group on microembolus detection. Stroke 29(3):725-729
16. Meier B (2005) Closure of patent foramen ovale: technique, pitfalls, complications, and follow-up. Heart 91:444-448
17. White RI Jr, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, Shuman K, Kim W, Kinnison M, Mitchell SE (1988) Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 169:663-669
18. Gossage JR, Kanj G (1998) Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 158:643-661
19. Mono ML, Geister L, Galimanis A, Jung S, Praz F, Arnold M, Fischer U, Wolff S, Findling O, Windecker S, Wahl A, Meier B, Mattle HP, Nedeltchev K (2011) Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events. Stroke (Epub a head)
20. Mas JL, Zuber M (1995) Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French study group on patent foramen ovale and atrial septal aneurysm. Am Heart J 130(5):1083-1088
21. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G (1996) Stroke recurrence in patients with patent foramen ovale: the Lausanne study. Lausanne stroke with paradoxal embolism study group. Neurology 46(5):1301-1305
22. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31(10):2407-2413
23. Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A (2011) FORI (foramen ovale registro Italiano) investigators. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (foramen ovale registro Italiano) study. Cerebrovasc Dis 31(2):109-116
24. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP (2004) Carotid endarterectomy trialists collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363(9413):915-924